Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Park, Hyun Young ^a   Jun, Chang Duk ^b   Jeon, Se Jeong ^a   Choi, See Sung ^a   Kim, Hak Ryul ^a   Choi, Dan Bee ^a   Kwak, Seongae ^a   Lee, Hak Seung ^a   Cheong, Jin Sung ^a   So, Hong Seob ^a,c   Lee, Young Jin ^a   Park, Do Sim ^a,c  

^a Wonkwang University   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ACUTE BRAIN ISCHEMIA; ADULT; AGED; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANKIN SCALE; RISK FACTOR; SYMPTOM;

ADIPOKINES; AGED; BRAIN INFARCTION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LECTINS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS;

EID: 84871296321     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051722     Document Type: Article

References (23)

1. Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA, (2010) In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation 7: 34.
2. Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, et al. (2011) Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One 6: e16032.
3. Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, et al. (2010) YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry 68: 903-912.
4. Bonneh-Barkay D, Zagadailov P, Zou H, Niyonkuru C, Figley M, et al. (2010) YKL-40 expression in traumatic brain injury: an initial analysis. J Neurotrauma 27: 1215-1223.
5. Bonneh-Barkay D, Bissel SJ, Kofler J, Starkey A, Wang G, et al. (2012) Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation. Brain Pathol 22: 530-546.
6. Kjaergaard AD, Bojesen SE, Johansen JS, Nordestgaard BG, (2010) Elevated plasma YKL-40 levels and ischemic stroke in the general population. Ann Neurol 68: 672-680.
7. Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, et al. (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211: 589-595.
8. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, et al. (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19: 687-694.
9. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, et al. (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5: 46.
10. Downes CE, Crack PJ, (2010) Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol 160: 1872-1888.
11. den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, et al. (2009) C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol 256: 2003-2008.
12. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, et al. (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4: 2.
13. Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L, (2009) Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. BMC Neurol 9: 18.
14. Youn CS, Choi SP, Kim SH, Oh SH, Jeong WJ, et al. (2012) Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. Am J Emerg Med 30: 124-128.
15. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D, (2002) Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33: 2459-2464.
16. Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, et al. (2009) Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis 28: 545-550.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
18. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J, (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19: 604-607.
19. van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP, (1998) Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 29: 1783-1790.
20. Coull BM, (2007) Inflammation and stroke: Introduction. Stroke 38: 631.
21. Ormstad H, Aass HC, Lund-Sørensen N, Amthor KF, Sandvik L, (2011) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258: 677-685.
22. Waje-Andreassen U, Kråkenes J, Ulvestad E, Thomassen L, Myhr KM, et al. (2005) IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 111: 360-365.
23. Kastrup J, (2012) Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? Immunobiology 217: 483-491.